Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Deal

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
Effect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer SurgeryMarjory Charlot, Jacob Newton Stein, Emily Damone, et al.
JCO Oncology Practice|June 9, 2023
Knowledge, Attitudes, and Resources of Frontline Oncology Support Personnel Regarding Financial Burden in Patients With CancerKatherine E Reeder-Hayes, Caitlin B Biddell, Michelle L Manning, et al.
The Annals of Pharmacotherapy|September 20, 2021
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid LeukemiaAndy H Szeto, Tyler Bucci, Allison Deal, et al.
Cancer Treatment and Research Communications|March 11, 2019
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinibJared Weiss, Brian Kavanagh, Allison Deal, et al.
Anti-Cancer Drugs|April 4, 2017
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapyOrit Kaidar-Person, Timothy M Zagar, Allison Deal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Impact of a Comprehensive Financial Navigation Intervention to Reduce Cancer-Related Financial ToxicityStephanie B Wheeler, Michelle L Manning, Mindy Gellin, et al.
Cancer|July 3, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinomaShetal A Patel, Michael K Gibson, Allison Deal, et al.
Clinical Breast Cancer|September 24, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation TherapyRyan T Morse, Nathan W Bean, Jacob Hall, et al.
Urologic Oncology|August 22, 2020
Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patientsAngela B Smith, Cleo A Samuel, Sean D McCabe, et al.
Neuro-Oncology|May 10, 2017
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancerAmanda E D Van Swearingen, Maria J Sambade, Marni B Siegel, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
Effect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer SurgeryMarjory Charlot, Jacob Newton Stein, Emily Damone, et al.
JCO Oncology Practice|June 9, 2023
Knowledge, Attitudes, and Resources of Frontline Oncology Support Personnel Regarding Financial Burden in Patients With CancerKatherine E Reeder-Hayes, Caitlin B Biddell, Michelle L Manning, et al.
The Annals of Pharmacotherapy|September 20, 2021
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid LeukemiaAndy H Szeto, Tyler Bucci, Allison Deal, et al.
Cancer Treatment and Research Communications|March 11, 2019
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinibJared Weiss, Brian Kavanagh, Allison Deal, et al.
Anti-Cancer Drugs|April 4, 2017
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapyOrit Kaidar-Person, Timothy M Zagar, Allison Deal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Impact of a Comprehensive Financial Navigation Intervention to Reduce Cancer-Related Financial ToxicityStephanie B Wheeler, Michelle L Manning, Mindy Gellin, et al.
Cancer|July 3, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinomaShetal A Patel, Michael K Gibson, Allison Deal, et al.
Clinical Breast Cancer|September 24, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation TherapyRyan T Morse, Nathan W Bean, Jacob Hall, et al.
Urologic Oncology|August 22, 2020
Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patientsAngela B Smith, Cleo A Samuel, Sean D McCabe, et al.
Neuro-Oncology|May 10, 2017
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancerAmanda E D Van Swearingen, Maria J Sambade, Marni B Siegel, et al.
Pageof 5